home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

353.93 +5.50 (+1.58%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

64 65 Next >

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

Via Investor Brand Network

Get Ready for Next Generation of Diabetes, Weight-Management Drugs

November 01, 2023

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END

Via FinancialNewsMedia

Investor patience tested as pharmaceutical stocks take a tumble

November 01, 2023

The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector

Via MarketBeat

Earnings Outlook For Amgen ↗

October 30, 2023

Via Benzinga

Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗

October 30, 2023

S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.

Via Benzinga

Topics Economy Stocks

Performance Comparison: Amgen And Competitors In Biotechnology Industry ↗

October 27, 2023

Via Benzinga

Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision ↗

November 01, 2023

The CNN Money Fear and Greed index remained in the "Fear" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely...

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

October 31, 2023

Via Benzinga

Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200 ↗

October 31, 2023

To gain an edge, this is what you need to know today.

Via Benzinga

Topics Economy

Looking At Amgen's Recent Unusual Options Activity ↗

October 23, 2023

Via Benzinga

Amgen Unusual Options Activity For October 17 ↗

October 17, 2023

Via Benzinga

$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today ↗

October 16, 2023

Via Benzinga

Amgen Lifts Annual Outlook After Q3 Performance, But Stock Still Falls - Here's Why ↗

October 31, 2023

Amgen Inc (NASDAQ: AMGN) reported Q3 FY23 sales of $6.90 billion, slightly missin

Via Benzinga

Amgen Boosts Outlook Following Horizon Takeover, But Dips On Light Enbrel Sales ↗

October 31, 2023

The company just finished its acquisition of Horizon Therapeutics this month.

Via Investor's Business Daily

U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive ↗

October 31, 2023

US stocks are priming for a modestly higher open on Tuesday as traders look to another slew of earnings and the Fed decision.

Via Benzinga

Topics Economy

Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient ↗

October 30, 2023

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

Via The Motley Fool

In-Depth Analysis: Amgen Versus Competitors In Biotechnology Industry ↗

October 13, 2023

Via Benzinga

Is This Dividend Stock a Screaming Buy After Its Latest Acquisition? ↗

October 13, 2023

The biotech is ending the year with a bang.

Via The Motley Fool

Is Amgen Stock a Buy Now? ↗

October 13, 2023

The company recently closed its acquisition of Horizon Therapeutics.

Via The Motley Fool

2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now ↗

October 29, 2023

These two defensive dividend stocks sport compelling valuations and attractive yields.

Via The Motley Fool

Topics Stocks

Microsoft Leads These 5 Dow Jones Stocks Near Buy Points ↗

October 28, 2023

Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.

Via Investor's Business Daily

Topics Stocks

Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets ↗

October 27, 2023

It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S....

Via Benzinga

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

3 Pharma Stocks That Are Screaming Buys in October ↗

October 26, 2023

Each company delivers an above-average dividend and revenue growth.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 25, 2023

Via Benzinga

Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030

October 25, 2023

EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END

Via FinancialNewsMedia

Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts ↗

October 24, 2023

Investors appear to be viewing Amgen's recent job cuts as a positive today, with buying pressure resulting in a 1% move higher in AMGN stock.

Via InvestorPlace

Topics Workforce

Why These 3 Equal-Weighted ETFs Deserve a Portfolio Spot

October 19, 2023

These three equally-weighted exchange traded funds that offer superior diversification and risk adjusted returns are worth a look.

Via MarketBeat

Topics ETFs

10 Health Care Stocks Whale Activity In Today's Session ↗

October 18, 2023

Via Benzinga

Johnson & Johnson Stock: Is Now the Time to Sell? ↗

October 14, 2023

Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff

Via InvestorPlace

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

64 65 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com